Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis

Arthritis and Rheumatism

Volumn 63, Issue 8, 2011, Pages 2238-2247

  Li, Xin ^a,d   McHugh, Gail A ^a   Damle, Nitin ^b   Sikand, Vijay K ^c   Glickstein, Lisa ^a   Steere, Allen C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b South County Internal Medicine   (United States)

^c Lawrence and Memorial Hospital   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; MESSENGER RNA; RIBOSOME RNA;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL LOAD; BACTERIAL VIABILITY; BACTERIUM CULTURE; BORRELIA BURGDORFERI; DISEASE DURATION; ERYTHEMA CHRONICUM MIGRANS; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELAPSE; SKIN DEFECT; SYNOVECTOMY; SYNOVIAL FLUID; SYNOVIUM;

ADULT; BACTERIAL LOAD; BORRELIA BURGDORFERI; GLOSSITIS, BENIGN MIGRATORY; HUMANS; LYME DISEASE; SKIN; SYNOVIAL FLUID;

EID: 79961113735     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30384     Document Type: Article

References (49)

1. Steere AC,. Lyme disease. N Engl J Med 2001; 345: 115-25. (Pubitemid 32640193)
2. Steere AC, Schoen RT, Taylor E,. The clinical evolution of Lyme arthritis. Ann Intern Med 1987; 107: 725-31. (Pubitemid 18041872)
3. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43: 1089-34.
4. Steere AC, Angelis SM,. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis [review]. Arthritis Rheum 2006; 54: 3079-86. (Pubitemid 44622076)
5. Berger BW, Johnson RC, Kodner C, Coleman L,. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J Clin Microbiol 1992; 30: 359-61.
6. Mitchell PD, Reed KD, Vandermause MF, Melski JW,. Isolation of Borrelia burgdorferi from skin biopsy specimens of patients with erythema migrans. Am J Clin Pathol 1993; 99: 104-7. (Pubitemid 23030682)
7. Steere AC, Sikand VK, Meurice F, Parenti DL, Fikrig E, Schoen RT, et al and the Lyme Disease Vaccine Study Group. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med 1998; 339: 209-15. (Pubitemid 28350162)
8. Nowakowski J, Schwartz I, Liveris D, Wang G, Aguero-Rosenfeld ME, Girao G, et al. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis 2001; 33: 2023-7. (Pubitemid 33152397)
9. Wormser GP, Bittker S, Cooper D, Nowakowski J, Nadelman RB, Pavia C,. Yield of large-volume blood cultures in patients with early Lyme disease. J Infect Dis 2001; 184: 1070-2. (Pubitemid 32955126)
10. Wormser GP, McKenna D, Carlin J, Nadelman RB, Cavaliere LF, Holmgren D, et al. Brief communication: hematogenous dissemination in early Lyme disease. Ann Intern Med 2005; 142: 751-5. (Pubitemid 40593777)
11. Steere AC, Grodzicki RL, Craft JE, Shrestha M, Kornblatt AN, Malawista SE,. Recovery of Lyme disease spirochetes from patients. Yale J Biol Med 1984; 57: 557-60. (Pubitemid 15151045)
12. Bradley JF, Johnson RC, Goodman JL,. The persistence of spirochetal nucleic acids in active Lyme arthritis. Ann Intern Med 1994; 120: 487-9. (Pubitemid 24075227)
13. Snydman DR, Schenkein DP, Berardi VP, Lastavica CC, Pariser KM,. Borrelia burgdorferi in joint fluid in chronic Lyme arthritis. Ann Intern Med 1986; 104: 798-800. (Pubitemid 16115045)
14. Schmidli J, Hunziker T, Moesli P, Schaad UB,. Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis. J Infect Dis 1988; 158: 905-6.
15. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC,. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994; 330: 229-34. (Pubitemid 24034134)
16. Jaulhac B, Chary-Valckenaere I, Sibilia J, Javier RM, Piemont Y, Kuntz JL, et al. Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. Arthritis Rheum 1996; 39: 736-45. (Pubitemid 26140418)
17. Priem S, Rittig MG, Kamradt T, Burmester GR, Krause A,. An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis. J Clin Microbiol 1997; 35: 685-90. (Pubitemid 27083862)
18. Priem S, Burmester GR, Kamradt T, Wolbart K, Rittig MG, Krause A,. Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy. Ann Rheum Dis 1998; 57: 118-21. (Pubitemid 28177543)
19. Carlson D, Hernandez J, Bloom BJ, Coburn J, Aversa JM, Steere AC,. Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum 1999; 42: 2705-9. (Pubitemid 30327194)
20. Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW,. Case definitions for public health surveillance. MMWR Recomm Rep 1990; 39: 1-43.
21. Vaz A, Glickstein L, Field JA, McHugh G, Sikand VK, Damle N, et al. Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Infect Immun 2001; 69: 7437-44. (Pubitemid 33089238)
22. Steere AC, McHugh G, Damle N, Sikand VK,. Prospective study of serologic tests for Lyme disease. Clin Infect Dis 2008; 47: 188-95. (Pubitemid 351920619)
23. Kannian P, McHugh G, Johnson BJ, Bacon RM, Glickstein LJ, Steere AC,. Antibody responses to Borrelia burgdorferi in patients with antibiotic- refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis. Arthritis Rheum 2007; 56: 4216-25. (Pubitemid 350262350)
24. Morrison TB, Ma Y, Weis JH, Weis JJ,. Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J Clin Microbiol 1999; 37: 987-92. (Pubitemid 29140602)
25. Craig-Mylius K, Weber GF, Coburn J, Glickstein L,. Borrelia burgdorferi, an extracellular pathogen, circumvents osteopontin in inducing an inflammatory cytokine response. J Leukoc Biol 2005; 77: 710-8. (Pubitemid 40628751)
26. Pahl A, Kuhlbrandt U, Brune K, Rollinghoff M, Gessner A,. Quantitative detection of Borrelia burgdorferi by real-time PCR. J Clin Microbiol 1999; 37: 1958-63. (Pubitemid 29235253)
27. Li X, Pal U, Ramamoorthi N, Liu X, Desrosiers DC, Eggers CH, et al. The Lyme disease agent Borrelia burgdorferi requires BB0690, a Dps homologue, to persist within ticks. Mol Microbiol 2007; 63: 694-710. (Pubitemid 46105896)
28. Alberts B, Bray D, Raff M, Roberts K, Watson JD,. The cell nucleus. In: Molecular biology of the cell. 3rd ed. New York: Garland Science; 1994. p 378.
29. Liveris D, Wang G, Girao G, Byrne DW, Nowakowski J, McKenna D, et al. Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J Clin Microbiol 2002; 40: 1249-53. (Pubitemid 34279884)
30. Keer JT, Birch L,. Molecular methods for the assessment of bacterial viability. J Microbiol Methods 2003; 53: 175-83. (Pubitemid 36332352)
31. Masters CI, Shallcross JA, Mackey BM,. Effect of stress treatments on the detection of Listeria monocytogenes and enterotoxigenic Escherichia coli by the polymerase chain reaction. J Appl Bacteriol 1994; 77: 73-9. (Pubitemid 24225096)
32. Josephson KL, Gerba CP, Pepper IL,. Polymerase chain reaction detection of nonviable bacterial pathogens. Appl Environ Microbiol 1993; 59: 3513-5. (Pubitemid 23296482)
33. Sheridan GE, Masters CI, Shallcross JA, MacKey BM,. Detection of mRNA by reverse transcription-PCR as an indicator of viability in Escherichia coli cells. Appl Environ Microbiol 1998; 64: 1313-8. (Pubitemid 28188389)
34. Hellyer TJ, DesJardin LE, Hehman GL, Cave MD, Eisenach KD,. Quantitative analysis of mRNA as a marker for viability of Mycobacterium tuberculosis. J Clin Microbiol 1999; 37: 290-5. (Pubitemid 29056392)
35. Lleo MM, Pierobon S, Tafi MC, Signoretto C, Canepari P,. mRNA detection by reverse transcription-PCR for monitoring viability over time in an Enterococcus faecalis viable but nonculturable population maintained in a laboratory microcosm. Appl Environ Microbiol 2000; 66: 4564-7.
36. Villarino A, Bouvet OM, Regnault B, Martin-Delautre S, Grimont PA,. Exploring the frontier between life and death in Escherichia coli: evaluation of different viability markers in live and heat- or UV-killed cells. Res Microbiol 2000; 151: 755-68.
37. Meijer A, Roholl PJ, Gielis-Proper SK, Meulenberg YF, Ossewaarde JM,. Chlamydia pneumoniae in vitro and in vivo: a critical evaluation of in situ detection methods. J Clin Pathol 2000; 53: 904-10.
38. McKillip JL, Jaykus LA, Drake M,. Nucleic acid persistence in heat-killed Escherichia coli O157:H7 from contaminated skim milk. J Food Prot 1999; 62: 839-44. (Pubitemid 29377471)
39. McKillip JL, Jaykus LA, Drake M,. rRNA stability in heat-killed and UV-irradiated enterotoxigenic Staphylococcus aureus and Escherichia coli O157:H7. Appl Environ Microbiol 1998; 64: 4264-8. (Pubitemid 28537986)
40. Tolker-Nielsen T, Larsen MH, Kyed H, Molin S,. Effects of stress treatments on the detection of Salmonella typhimurium by in situ hybridization. Int J Food Microbiol 1997; 35: 251-8. (Pubitemid 27148438)
41. Hellyer TJ, Fletcher TW, Bates JH, Stead WW, Templeton GL, Cave MD, et al. Strand displacement amplification and the polymerase chain reaction for monitoring response to treatment in patients with pulmonary tuberculosis. J Infect Dis 1996; 173: 934-41. (Pubitemid 26001170)
42. Moore DF, Curry JI, Knott CA, Jonas V,. Amplification of rRNA for assessment of treatment response of pulmonary tuberculosis patients during antimicrobial therapy. J Clin Microbiol 1996; 34: 1745-9. (Pubitemid 26190409)
43. Steere AC, Hardin JA, Ruddy S, Mummaw JG, Malawista SE,. Lyme arthritis: correlation of serum and cryoglobulin IgM with activity, and serum IgG with remission. Arthritis Rheum 1979; 22: 471-83. (Pubitemid 10146143)
44. Barthold SW, Beck DS, Hansen GM, Terwilliger GA, Moody KD,. Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis 1990; 162: 133-8. (Pubitemid 20223961)
45. Bockenstedt LK, Mao J, Hodzic E, Barthold SW, Fish D,. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment. J Infect Dis 2002; 186: 1430-7. (Pubitemid 35286110)
46. Hodzic E, Feng S, Holden K, Freet KJ, Barthold SW,. Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother 2008; 52: 1728-36. (Pubitemid 351614666)
47. Wormser GP, Schwartz I,. Antibiotic treatment of animals infected with Borrelia burgdorferi. Clin Microbiol Rev 2009; 22: 387-95.
48. Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, Luft B,. Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob Agents Chemother 2010; 54: 643-51.
49. Steere AC, Glickstein L,. Elucidation of Lyme arthritis. Nat Rev Immunol 2004; 4: 143-52. (Pubitemid 38209208)